IGF2BP3 and gastric cancer: For instance, elevated levels of YTHDF1 and YTHDC2 are adverse prognostic factors for gastric cancer (GC) [10,11], while increased IGF2BP3 levels are adverse prognostic factors for bladder cancer [12].